These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15785307)

  • 1. Relationship between paraoxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region.
    Göçmen YA; Semiz E; Gümüşlü S
    Eur J Cardiovasc Prev Rehabil; 2005 Apr; 12(2):185-6. PubMed ID: 15785307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?
    Göçmen AY; Sahin E; Semiz E; Gümuşlü S
    Can J Cardiol; 2008 Mar; 24(3):209-12. PubMed ID: 18340391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in turkish patients with type 2 diabetes mellitus.
    Agachan B; Yilmaz H; Ergen HA; Karaali ZE; Isbir T
    Physiol Res; 2005; 54(3):287-93. PubMed ID: 15974833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human paraoxonase Gln-Argl92 (Q/R) polymorphism in turkish patients with coronary artery disease.
    Aynacioglu AS; Kepekci Y
    Int J Cardiol; 2000 Jun; 74(1):33-7. PubMed ID: 10854678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lipoprotein (a) [Lp (a)] as a risk factor for coronary artery disease in the Turkish population.
    Orem A; Değer O; Kulan K; Onder E; Kiran E; Uzunosmanoğlu D
    Clin Biochem; 1995 Apr; 28(2):171-3. PubMed ID: 7628076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease.
    Granér M; James RW; Kahri J; Nieminen MS; Syvänne M; Taskinen MR
    J Am Coll Cardiol; 2006 Jun; 47(12):2429-35. PubMed ID: 16781370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteina(a) is a feature of the presence, diffuseness, and severity of coronary artery disease in Saudi population.
    Habib SS; Abdel-Gader AM; Kurdi MI; Al-Aseri Z; Soliman MM
    Saudi Med J; 2009 Mar; 30(3):346-52. PubMed ID: 19271061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
    Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
    Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
    Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
    Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
    Ito T; Yasue H; Yoshimura M; Nakamura S; Nakayama M; Shimasaki Y; Harada E; Mizuno Y; Kawano H; Ogawa H
    Hum Genet; 2002 Jan; 110(1):89-94. PubMed ID: 11810302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) as a marker of coronary artery disease and its association with dietary fat.
    Burman A; Jain K; Gulati R; Chopra V; Agarwal DP; Vasisht S
    J Assoc Physicians India; 2004 Feb; 52():99-102. PubMed ID: 15656041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein(A) distribution among adults and its relation to the incidence of coronary artery disease in Changsha City].
    Li X; Zhao S; Wang Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):320-2. PubMed ID: 9868086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
    Gupta R; Vasisht S; Bahl VK; Wasir HS
    Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
    Sharma R; Singh B; Mahajan M
    Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.